“…CBI values from Lutz (1979) unless stated otherwise in the list of abbreviations arranged below in increasing carcinogenic potency. Bz, benzene; CCI 4 , carbon tetrachloride (Levy and Brabec 1984); Ani, aniline (McCarthy et al 1985); AcrN, acrylonitrile (Farooqui and Ahmed 1983); VC, vinyl chloride (Bergman 1982); Safr, safrole (Randerath et al 1984); TCE, 1,1,2-trichloroethane ; tBPP, tris(2,3-dibromopropyl)phosphate (Morales and Matthews 1980); Ure, urethane; CMAni, 4-chloro-2-methylaniline (unpublished); NMAni, nitrosomethylaniline; DCE, 1 ,2-dichloroethane ; DNT, 2,4-dinitrotoluene (Kedderis et al 1984); NPyrr, nitrosopyrrolidine (Hunt and Shank 1982); BP, benzo[a]pyrene (Shertzer 1983); DMAAB, N,N-dimethyl-4-aminoazobenzene FANFT, N-[5-nitro-2-furyl)-2-thiazolyl]formamide (Morton 1982); CPh, cyclophosphamide; Bzd, benzidine (Martin and Ekers 1980); DBE, 1,2-dibromoethane; AAF, 2-acetylaminofluorene; Aza, azaserine (Zurlo et al 1982); NDMA, nitrosodimethylamine; Strtoz, streptozotocin (Bennett and Pegg 1981); DMH, 1,2-dimethylhydrazine; Steri, sterigmatocystine ; Pcz, procarbazine (Wiestler et al 1984); NDEA, nitrosodiethylamine; AFB 1 , aflotoxin B 1 potency with DNA binding ability. Firstly, most sturlies have concentrated on the Ievel of DNA binding at the time ofmaximum DNA darnage after a single administration.…”